Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study.
Alda scale
bipolar disorder
indoleamine 2,3 dioxygenase (IDO)
kynurenine
lithium response
tryptophan
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Apr 2022
29 Apr 2022
Historique:
received:
16
02
2022
revised:
15
04
2022
accepted:
27
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
Bipolar disorder is associated with an inflammation-triggered elevated catabolism of tryptophan to the kynurenine pathway, which impacts psychiatric symptoms and outcomes. The data indicate that lithium exerts anti-inflammatory effects by inhibiting indoleamine-2,3-dioxygenase (IDO)-1 activity. This exploratory study aimed to investigate the tryptophan catabolism in individuals with bipolar disorder (
Identifiants
pubmed: 35566641
pii: jcm11092517
doi: 10.3390/jcm11092517
pmc: PMC9103936
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Mol Psychiatry. 2010 Apr;15(4):393-403
pubmed: 19918244
Pharmacopsychiatry. 1985 Mar;18(2):214-7
pubmed: 3927331
Int J Bipolar Disord. 2017 Dec;5(1):24
pubmed: 28480482
Biomedicines. 2021 Jun 25;9(7):
pubmed: 34202246
J Neurochem. 1991 Jun;56(6):2007-17
pubmed: 1827495
Biomedicines. 2021 Nov 19;9(11):
pubmed: 34829952
J Clin Psychopharmacol. 2002 Feb;22(1):86-90
pubmed: 11799348
Pharmacol Rep. 2011;63(6):1569-73
pubmed: 22358107
Brain Behav Immun. 2020 Jul;87:404-412
pubmed: 31978524
PLoS One. 2017 Feb 27;12(2):e0172699
pubmed: 28241062
Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(2-3):325-34
pubmed: 2819953
World J Biol Psychiatry. 2019 Nov;20(9):703-711
pubmed: 29683396
Int J Tryptophan Res. 2019 Aug 21;12:1178646919868978
pubmed: 31488951
Mol Psychiatry. 2021 Jul;26(7):3419-3429
pubmed: 33077852
Acta Psychiatr Scand. 2021 Sep;144(3):259-276
pubmed: 33960396
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
Glia. 2022 Mar;70(3):558-571
pubmed: 34862988
J Psychiatr Res. 2013 Sep;47(9):1119-33
pubmed: 23768870
Bipolar Disord. 2018 Feb;20(1):27-34
pubmed: 28833866
FASEB J. 1991 Aug;5(11):2516-22
pubmed: 1907934
Mol Psychiatry. 2021 Aug;26(8):4158-4178
pubmed: 33230205
Brain Behav Immun. 2015 Jan;43:110-7
pubmed: 25124710
Brain Behav Immun. 2020 Oct;89:175-183
pubmed: 32531426
J Affect Disord. 2007 Sep;102(1-3):65-72
pubmed: 17270276
J Clin Pharmacol. 1994 Apr;34(4):280-5
pubmed: 8006194
Mol Psychiatry. 2020 Nov;25(11):2860-2872
pubmed: 30940904
Blood. 1994 Mar 1;83(5):1408-11
pubmed: 8118042
Bipolar Disord. 2007 Sep;9(6):596-602
pubmed: 17845274
J Psychiatry Neurosci. 2010 May;35(3):195-9
pubmed: 20420770
Curr Psychiatry Rep. 2015 Feb;17(2):8
pubmed: 25620790
In Vivo. 2014 Jul-Aug;28(4):633-8
pubmed: 24982234
Psychoneuroendocrinology. 2011 Apr;36(3):426-36
pubmed: 21041030
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Front Psychiatry. 2018 Aug 21;9:360
pubmed: 30186186
J Affect Disord. 2019 Dec 1;259:404-412
pubmed: 31610997
Eur Neuropsychopharmacol. 2022 Feb;55:96-109
pubmed: 34847455
Lancet Diabetes Endocrinol. 2015 Mar;3(3):207-15
pubmed: 25066177
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):507-526
pubmed: 33124585
Mol Psychiatry. 2014 Mar;19(3):334-41
pubmed: 23459468
Eur J Pharmacol. 2006 Jul 17;541(3):147-51
pubmed: 16765940
Curr Psychiatry Rep. 2009 Dec;11(6):488-93
pubmed: 19909672
Mol Psychiatry. 2018 Nov;23(11):2184-2191
pubmed: 29426954
J Acquir Immune Defic Syndr (1988). 1990;3(9):873-6
pubmed: 2166783
Int J Bipolar Disord. 2019 Dec 9;7(1):27
pubmed: 31814040
J Affect Disord. 2015 Oct 1;185:219-29
pubmed: 26241867
Pharmacopsychiatry. 1997 May;30(3):106-7
pubmed: 9211572
Antioxidants (Basel). 2021 Nov 10;10(11):
pubmed: 34829665
PLoS One. 2013 Jun 19;8(6):e65636
pubmed: 23840348
Nat Rev Neurosci. 2012 Jul;13(7):465-77
pubmed: 22678511
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Neuropsychopharmacology. 2012 Mar;37(4):939-49
pubmed: 22071871
Int J Bipolar Disord. 2019 Sep 25;7(1):20
pubmed: 31552554
Eur Neuropsychopharmacol. 2021 Feb;43:52-62
pubmed: 33339712
Front Psychiatry. 2018 Jun 14;9:250
pubmed: 29962973
Obesity (Silver Spring). 2014 Jan;22(1):195-201
pubmed: 23625535
J Clin Psychiatry. 2002 Oct;63(10):942-7
pubmed: 12416605
Curr Drug Metab. 2007 Apr;8(3):289-95
pubmed: 17430117
Pteridines. 2015 Jun;26(2):79-84
pubmed: 26251562
Chronobiol Int. 2016;33(4):351-73
pubmed: 27003509
Adv Clin Chem. 2020;95:165-218
pubmed: 32122523
Brain Behav Immun. 2016 Jul;55:225-235
pubmed: 26593276
Clin Exp Immunol. 2006 Sep;145(3):469-73
pubmed: 16907915
Neuropharmacology. 2017 Jan;112(Pt B):307-323
pubmed: 26690895
Neurochem Int. 2008 May;52(6):1297-303
pubmed: 18328600
PLoS One. 2020 Jan 27;15(1):e0225353
pubmed: 31986152
Curr Top Med Chem. 2021 Sep 09;:
pubmed: 34503408
Food Chem Toxicol. 2020 Feb;136:110986
pubmed: 31760073
Br J Med Psychol. 1959;32(1):50-5
pubmed: 13638508
Commun Psychopharmacol. 1977;1(2):135-45
pubmed: 603996
Psychiatry Res. 1997 Jul 4;71(2):67-76
pubmed: 9255851
J Affect Disord. 2007 Dec;104(1-3):185-90
pubmed: 17442400
J Neuroinflammation. 2005 Jul 26;2:16
pubmed: 16042813
Neuropsychopharmacology. 2005 Jul;30(7):1400-4
pubmed: 15841104
Bipolar Disord. 2014 Jun;16(4):432-40
pubmed: 24330408
J Clin Psychiatry. 2003;64 Suppl 6:18-22; discussion 28
pubmed: 12720476
Am J Psychiatry. 2005 Oct;162(10):1805-19
pubmed: 16199826
J Neuroinflammation. 2014 Aug 14;11:140
pubmed: 25115727
Neuropsychobiology. 2020;79(1):89-99
pubmed: 30808841